SLNO stock forecast
Our latest prediction for Soleno Therapeutics, Inc.'s stock price was made on the June 26, 2020 when the stock price was at 1.84$.
In the short term (2weeks), SLNO's stock price should outperform the market by 6.07%. During that period the price should oscillate between -11.44% and +26.07%.
In the medium term (3months), SLNO's stock price should underperform the market by -1.75%. During that period the price should oscillate between -45.93% and +57.59%.Get email alerts
Create a solid portfolio with SLNO
About Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. The company focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.
At the moment the company generates 1M USD in revenues.
On its last earning announcement, the company reported a loss of -0.81$ per share.
The book value per share is 0.74$
Three months stock forecastJune 26, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|